COVID-19 test kit

for antigensCRPcTnI

Features & Characteristics: 1. Affordable 2. User friendly design 3. Minimal laboratory operation 5. Traceable result for up to 5,000 result memories 6. Compact size for easy transportation & storage 7. Complementary panel for other covid-19 related bio-markers (cTnI/CK-MB/Myo, D-Dimer, PCT, CRP) WHO Suggested Application Scenarios: 1. To identify suspected outbreaks of COVID-19 in regions where NAAT is not immediately available 2. To screen at risk individuals and prioritize positive sample for further NAAT confirmation during outbreak 3. Early detection and isolation of positive cases in health facilities, testing centers, airport, customs, prisons, schools, front-line and health-care workers 4. To test asymptomatic contacts of positive cases Clinical Benefits: 1. Detect the presence of 2019-nCoV nucleocapsid protein antigen 2. Solely used as a supplementary test indicator in: - Suspected cases with negative nucleic acid test result - Conjunction with nucleic acid test in the diagnosis of suspected cases 3. Identify the most infectious status of a COVID-19 positive person within the first seven days of symptom onset